SOPHiA Genetics Executives Sell 30,000 Shares on Volatile Day, But Analysts Say It’s Just a Routine Tax‑Plan Move
Inside SOPHiA Genetics’ October 5 insider sales: a tax‑planning move, not panic, showing exec confidence and long‑term growth outlook.
3 minutes to read
